Montagne Company Case Summary

949 Words4 Pages
Business risk of GSAP they are going to buy: that it will not fail o Business risk= more business risk means more variability in operating profit which means a higher beta so adjust the Beta coefficient to match it with the level of financial risk incurred by the company. • Beta: Sterling’s proposed acquisition is 0.99 (beta is leveraged on the debt/equity ratio) [Exhibit 7] • Growth opportunities were limited and its business was under constant pressure • The company’s annual sales volume (in units) had increased by less than 1% per year, because of weak growth in overall demand and other company competition, which gives consumers the ability to choose other products • Business risk of buying at $265 million: relevantly low (where there…show more content…
• If PE ratios show how much growth (Montagne is growing better and faster) o Sterling expenses are going more than depreciation which is lower than Montagne o Expected to have Montagne PE to be higher (not only by a 0.2 difference) • PE of Montagne is so low and PE of Sterling is so high because it is over valued o Very diversified with beta • [Exhibit 1] Sterling’s operating expenses and commodities costs = rising faster than inflation rate: therefore more pressure on business profits Financial risk: by looking at the trends of coverage ratios, there is medium financial risk because Sterling is doing the borrowing o The higher working capital rate of Montagne Medical indicated financial risk in the Medicare/Healthcare market o Receivables are outstanding longer and there are greater risks of write offs for future o Inventory rates are higher and should be financially controlled/overlooked Beta [Exhibit 3]: • Beta for division: they are buying which is not the same for overall (diversified business) • Do not have returns for the division they are buying in • Division doesn’t trade in the market (doesn’t have a market price)- main challenge • Value of beta = 0.99 • Market premium = 5.0% • Risk free rate =…show more content…
Recommendations: • I would suggest (from an analytical perspective) getting the terminal value to estimate the expected value of unit acquisition with 2.2% growth rate o Also suggest not to acquire Montagne (business and financial risk on Sterling Company) • Sterling’s management should focus on the acquisition of Germicidal, Sanitation, and Antiseptic product division of Montagne Medical= high potentials of synergies (market for germicidal, sanitation and antiseptic products for use is growing fast • Device a monthly liquidity plan, keep contacts from Montagne Medical, and increase cash/short term bank payables after purchase o Risk in short term liquidity increases because higher working capital Explain why you would either make this acquisition or pass it up: • Valuation: free cash flow: EBIT + (1- tax rate) • Value of the unit acquisition = $ 171 million • It will not be worthwhile or successful (financially) for Sterling to acquire Montagne because its calculated value is less than purchase price • Discounted cash flows for the unit acquisition (without the option of capacity expansion): o Unit of the Montagne is not worth $265 million o Calculated worth of the unit is to be less than the negotiated value of $265

More about Montagne Company Case Summary

Open Document